These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 14566839)

  • 41. Characterization of HLA-A3-restricted cytotoxic T lymphocytes reactive against the widely expressed tumor antigen telomerase.
    Vonderheide RH; Anderson KS; Hahn WC; Butler MO; Schultze JL; Nadler LM
    Clin Cancer Res; 2001 Nov; 7(11):3343-8. PubMed ID: 11705846
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Identification of helper T-cell epitopes that encompass or lie proximal to cytotoxic T-cell epitopes in the gp100 melanoma tumor antigen.
    Kobayashi H; Lu J; Celis E
    Cancer Res; 2001 Oct; 61(20):7577-84. PubMed ID: 11606397
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Induction of antitumor cytotoxic T lymphocytes from the peripheral blood mononuclear cells of cancer patients using HLA-A2-restricted MAGE-3 peptide in vitro.
    Fujie T; Tanaka F; Mori M; Takesako K; Sugimachi K; Akiyoshi T
    Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2425-30. PubMed ID: 9815643
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Identification of alpha-fetoprotein-derived peptides recognized by cytotoxic T lymphocytes in HLA-A24+ patients with hepatocellular carcinoma.
    Mizukoshi E; Nakamoto Y; Tsuji H; Yamashita T; Kaneko S
    Int J Cancer; 2006 Mar; 118(5):1194-204. PubMed ID: 16152611
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Identification of an antigenic epitope for helper T lymphocytes from carcinoembryonic antigen.
    Kobayashi H; Omiya R; Ruiz M; Huarte E; Sarobe P; Lasarte JJ; Herraiz M; Sangro B; Prieto J; Borras-Cuesta F; Celis E
    Clin Cancer Res; 2002 Oct; 8(10):3219-25. PubMed ID: 12374692
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Therapy of established tumors in a novel murine model transgenic for human carcinoembryonic antigen and HLA-A2 with a combination of anti-idiotype vaccine and CTL peptides of carcinoembryonic antigen.
    Saha A; Chatterjee SK; Foon KA; Celis E; Bhattacharya-Chatterjee M
    Cancer Res; 2007 Mar; 67(6):2881-92. PubMed ID: 17363612
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Immunogenicity of HLA-A1-restricted peptides derived from S100A4 (metastasin 1) in melanoma patients.
    Hofmeister-Mueller V; Vetter-Kauczok CS; Ullrich R; Meder K; Lukanidin E; Broecker EB; Straten Pt; Andersen MH; Schrama D; Becker JC
    Cancer Immunol Immunother; 2009 Aug; 58(8):1265-73. PubMed ID: 19139886
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A nonapeptide encoded by human gene MAGE-1 is recognized on HLA-A1 by cytolytic T lymphocytes directed against tumor antigen MZ2-E.
    Traversari C; van der Bruggen P; Luescher IF; Lurquin C; Chomez P; Van Pel A; De Plaen E; Amar-Costesec A; Boon T
    J Exp Med; 1992 Nov; 176(5):1453-7. PubMed ID: 1402688
    [TBL] [Abstract][Full Text] [Related]  

  • 49. In vitro reactivity of allospecific cytotoxic T lymphocytes does not explain the taboo phenomenon.
    Stobbe I; van der Meer-Prins E; Smits JM; Doxiadis II; Claas FH
    Transpl Immunol; 1999 Dec; 7(4):215-20. PubMed ID: 10638834
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Nucleophosmin is recognized by a cytotoxic T cell line derived from a rectal carcinoma patient.
    Swoboda RK; Somasundaram R; Caputo L; Berencsi K; von Franzke P; Taylor DD; Marincola FM; Meropol NJ; Sigurdson E; Miller E; Herlyn D
    Int J Cancer; 2010 Sep; 127(5):1124-30. PubMed ID: 20027629
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Sp17 Protein Expression and Major Histocompatibility Class I and II Epitope Presentation in Diffuse Large B Cell Lymphoma Patients.
    Ait-Tahar K; Anderson AP; Barnardo M; Collins GP; Hatton CSR; Banham AH; Pulford K
    Adv Hematol; 2017; 2017():6527306. PubMed ID: 29204156
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Identification of epitopes for CTCL-specific cytotoxic T lymphocytes.
    Linnemann T; Brock C; Sparbier K; Muche M; Mielke A; Lukowsky A; Sterry W; Kaltoft K; Wiesmüller KH; Walden P
    Adv Exp Med Biol; 1998; 451():231-5. PubMed ID: 10026877
    [No Abstract]   [Full Text] [Related]  

  • 53. Subtypes of HLA-A1 defined on the basis of CTL precursor frequencies.
    Zhang L; Rinke de Wit TF; Li SG; van Rood JJ; Claas FH
    Hum Immunol; 1990 Feb; 27(2):80-9. PubMed ID: 2298611
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cancer testis antigen Sperm Protein 17 as a new target for triple negative breast cancer immunotherapy.
    Mirandola L; Pedretti E; Figueroa JA; Chiaramonte R; Colombo M; Chapman C; Grizzi F; Patrinicola F; Kast WM; Nguyen DD; Rahman RL; Daver N; Ruvolo P; Post SM; Bresalier RS; Chiriva-Internati M
    Oncotarget; 2017 Sep; 8(43):74378-74390. PubMed ID: 29088794
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The cancer-testis antigen, sperm protein 17, a new biomarker and immunological target in head and neck squamous cell carcinoma.
    Schutt CA; Mirandola L; Figueroa JA; Nguyen DD; Cordero J; Bumm K; Judson BL; Chiriva-Internati M
    Oncotarget; 2017 Nov; 8(59):100280-100287. PubMed ID: 29245977
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Identification of sperm antigen targets for immunocontraception: B-cell epitope analysis of Sp17.
    O'Rand MG; Widgren EE
    Reprod Fertil Dev; 1994; 6(3):289-96. PubMed ID: 7530380
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Failure to find interference between anti-HLA antibodies and chlorpromazine.
    Alexander RC; Coggiano MA; Wyatt RJ
    Biol Psychiatry; 1990 Mar; 27(6):642-8. PubMed ID: 2322624
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Decitabine treatment sensitizes tumor cells to T-cell-mediated cytotoxicity in patients with myelodysplastic syndromes.
    Zhang Z; He Q; Tao Y; Guo J; Xu F; Wu LY; Zhao YS; Wu D; Zhou LY; Su JY; Song LX; Xiao C; Li X; Chang CK
    Am J Transl Res; 2017; 9(2):454-465. PubMed ID: 28337274
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Sperm Protein 17 Expression by Murine Epithelial Ovarian Cancer Cells and Its Impact on Tumor Progression.
    Gao Q; Xiang SD; Wilson K; Madondo M; Stephens AN; Plebanski M
    Cancers (Basel); 2018 Aug; 10(8):. PubMed ID: 30127274
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A Nanoparticle Based Sp17 Peptide Vaccine Exposes New Immuno-Dominant and Species Cross-reactive B Cell Epitopes.
    Xiang SD; Gao Q; Wilson KL; Heyerick A; Plebanski M
    Vaccines (Basel); 2015 Oct; 3(4):875-93. PubMed ID: 26529027
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.